First Tracks Biotherapeutics TRAX
First Tracks Biotherapeutics, Inc. · Nasdaq · Pharmaceutical Preparations
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Sept. 2, 2026 | J. Anthony Ware director | Sold | 39,265 | $44.78 | $1.76 million |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 20 →Entry into a material definitive agreement · Financial statements and exhibits
AI summary, unreviewedFirst Tracks Biotherapeutics closes private placement of 6,106,870 shares with resale registration rights
Entry into a material definitive agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
Regulation FD disclosure · Other events · Financial statements and exhibits